Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thioguanine versus mercaptopurine in pediatric acute lymphoblastic leukemia
IRCT20241202063919N1Phase 4Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tioguanine and mercaptopurine in acute lymphoblastic leukemia (ALL) (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: Hepatotoxicity, Bone marrow relapse and 4 more. Started Apr 2025; status: completed.
02
Drugs
tioguaninemercaptopurine
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on IRCT20241202063919N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241202063919N1.